Literature DB >> 18458249

Identifying outpatients with renal insufficiency before contrast-enhanced CT by using estimated glomerular filtration rates versus serum creatinine levels.

Brian R Herts1, Erika Schneider, Emilio D Poggio, Nancy A Obuchowski, Mark E Baker.   

Abstract

PURPOSE: To determine whether using estimated glomerular filtration rate (eGFR) values rather than serum creatinine levels to identify patients with renal insufficiency facilitates any substantial change in the number of outpatients scheduled for computed tomography (CT) who are considered at increased risk for contrast medium-induced nephropathy.
MATERIALS AND METHODS: The study was HIPAA compliant and institutional review board approved for medical chart review; the requirement for informed patient consent was waived. Patients (n = 5138; 2569 women, 2569 men, 753 African Americans, 4385 non-African Americans) examined during a 2-year period formed the final study group after exclusion of patients undergoing dialysis (n = 49), for whom no age data were recorded (n = 9), and younger than 18 years (n = 113). Patient age, sex, and race and the blood urea nitrogen, albumin, and serum creatinine levels most recently measured within 6 months before CT were obtained from the electronic medical records. The number of patients with creatinine levels higher than 1.4 mg/dL was directly compared with the number of patients with eGFR values (calculated with four- and six-variable Modification of Diet in Renal Disease [MDRD] equations) lower than 60 mL/min/1.73 m(2) by using the two-tailed McNemar test. For 2689 patients, data to calculate the eGFR by using the four-variable equation were available, and for 2005 patients, data to calculate the eGFR by using the six-variable equation were available.
RESULTS: Among the outpatients scheduled to undergo CT, the percentage of patients with an eGFR lower than 60 mL/min/1.73 m(2) was significantly greater than the percentage of patients with a creatinine level higher than 1.4 mg/dL for both the four-variable (412 [15.3%] vs 166 [6.2%] of 2689 patients) and the six-variable (346 [17.3%] vs 117 [5.8%] of 2005 patients) MDRD equation groups (P < .001).
CONCLUSION: A significantly higher number of outpatients scheduled for contrast medium-enhanced CT met the National Kidney Foundation criteria for renal insufficiency when the MDRD equations were used to estimate the glomerular filtration rate compared with the number of outpatients who met the criteria on the basis of elevated creatinine levels. (c) RSNA, 2008.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18458249     DOI: 10.1148/radiol.2481071528

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  16 in total

Review 1.  Contrast-induced nephropathy in CT: incidence, risk factors and strategies for prevention.

Authors:  Shu Min Tao; Julian L Wichmann; U Joseph Schoepf; Stephen R Fuller; Guang Ming Lu; Long Jiang Zhang
Journal:  Eur Radiol       Date:  2015-12-18       Impact factor: 5.315

Review 2.  Current status of contrast-induced nephropathy and nephrogenic systemic fibrosis in children.

Authors:  Musturay Karcaaltincaba; Berna Oguz; Mithat Haliloglu
Journal:  Pediatr Radiol       Date:  2009-06

3.  Assessing renal function with a rapid, handy, point-of-care whole blood creatinine meter before using contrast materials.

Authors:  Satoru Morita; Kazufumi Suzuki; Ai Masukawa; Eiko Ueno
Journal:  Jpn J Radiol       Date:  2011-04-26       Impact factor: 2.374

4.  Significant differences when using MDRD for GFR estimation compared to radionuclide measured clearance.

Authors:  A J Craig; A Britten; S D Heenan; A G Irwin
Journal:  Eur Radiol       Date:  2011-05-21       Impact factor: 5.315

5.  Contrast medium-induced nephrotoxicity risk assessment in adult inpatients: a comparison of serum creatinine level- and estimated glomerular filtration rate-based screening methods.

Authors:  Matthew S Davenport; Shokoufeh Khalatbari; Richard H Cohan; James H Ellis
Journal:  Radiology       Date:  2013-04-11       Impact factor: 11.105

6.  Screening patients to assess renal function before administering gadolinium chelates: assessment of the Choyke questionnaire.

Authors:  Brena F Sena; Julia P Stern; Pari V Pandharipande; Barbara Klemm; Julie Bulman; Ivan Pedrosa; Neil M Rofsky
Journal:  AJR Am J Roentgenol       Date:  2010-08       Impact factor: 3.959

7.  Risk of nephropathy after consumption of nonionic contrast media by children undergoing cardiac angiography: a prospective study.

Authors:  Ghloamhossein Ajami; Ali Derakhshan; Hamid Amoozgar; Mohammad Mohamadi; Mohammad Borzouee; Mitra Basiratnia; Saeid Abtahi; Sirous Cheriki; Manochehr Soltani
Journal:  Pediatr Cardiol       Date:  2010-02-27       Impact factor: 1.655

Review 8.  The effectiveness of N-Acetylcysteine in preventing contrast-induced nephropathy in patients undergoing contrast-enhanced computed tomography: a meta-analysis of randomized controlled trials.

Authors:  Mei-Yi Wu; Hui-Fen Hsiang; Chung-Shun Wong; Min-Szu Yao; Yun-Wen Li; Chao-Ying Hsiang; Chyi-Huey Bai; Yung-Ho Hsu; Yuh-Feng Lin; Ka-Wai Tam
Journal:  Int Urol Nephrol       Date:  2013-01-03       Impact factor: 2.370

9.  Risk factors for contrast induced nephropathy: a study among Italian patients.

Authors:  Salvatore Evola; Monica Lunetta; Francesca Macaione; Giuseppe Fonte; Gaspare Milana; Egle Corrado; Francesca Bonura; Giuseppina Novo; Enrico Hoffmann; Salvatore Novo
Journal:  Indian Heart J       Date:  2012-07-27

10.  Safety of a rapid outpatient hydration protocol for patients with renal impairment requiring intravenous iodinated contrast media for computed tomography.

Authors:  Nicole Kessa Wee; Siew Ching Tiong; Chau Hung Lee; Martin Weng Chin H'ng
Journal:  Singapore Med J       Date:  2020-05-27       Impact factor: 1.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.